German biotech startup Ovo Labs has developed new technologies to “rejuvenate” human eggs, potentially boosting the chances of conception. The therapeutics are designed to enhance in vitro fertilisation (IVF), one of the most transformative advances in reproductive medicine. The first baby was born via IVF more than 40 years ago. Since then, the technology has helped millions of women get pregnant. However, IVF can put significant emotional, psychological, and financial strain on patients. It is often unsuccessful on the first attempt. Some try multiple times without success. For many, IVF ultimately does not lead to parenthood. Ovo Labs wants to…This story continues at The Next Web [...]
Artificial intelligence agents powered by the world's most advanced language models routinely fail to complete even straightforward professional tasks on their own, according to groundbreaking re [...]
Oura has redesigned its official app with a refreshed visual interface and new health-tracking insights. The company boasts that the app refresh offers "modern visual language with deeper persona [...]
Despite growing chatter about a future when much human work is automated by AI, one of the ironies of this current tech boom is how stubbornly reliant on human beings it remains, specifically the proc [...]
Imagine you do two things on a Monday morning.First, you ask a chatbot to summarize your new emails. Next, you ask an AI tool to figure out why your top competitor grew so fast last quarter. The AI si [...]
We've known Star Trek: Starfleet Academy was coming for a while now, but we finally have some real footage. Paramount just dropped a trailer, in addition to an official announcement that the show [...]